Is GHRS up or down today?
GHRS is up 0.07% today, last at 27.98. This stock moved +0.07% versus the prior close.
GHRS · GHRS
GHRS (GHRS) is trading at 27.98, up 0.07% on the session. Price action and momentum indicators lean constructive.
Over the past 7 days, 12 headlines skew mixed. Earnings and Analyst Rating themes dominated coverage. Stories with measurable price impact averaged +3.48% — the market reacted positively.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
GHRS is up 0.07% today, last at 27.98. This stock moved +0.07% versus the prior close.
Over the past 7 days, 12 headlines skew mixed. Earnings and Analyst Rating themes dominated coverage. Stories with measurable price impact averaged +3.48% — the market reacted positively. Dominant story: GHRS Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances Clinical Pipeline - Earnings Revision Upgrade - dars.gov.et (2 sources, bearish) RSI is 58 — leaning bullish Price above 50-day average — short-term uptrend Social (demo): 43% of recent mentions lean bullish — mixed social mood.
Loaded: Jan 2026 – Jul 2026 (124 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: GHRS
7/ 100 index
Based on 11,799 mentions over 30d
GHRS Q1 2026 Earnings: Clinical-Stage Biotech Reports Wider-Than-Expected Loss - Dividend Cut Risk - dars.gov.et
CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today – Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners - Stocktwits
GH Research (GHRS) Stock Looks Stretched On Its 111% YTD Run - simplywall.st
GH Research PLC (GHRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GHRS Initiated Coverage by Wells Fargo -- Price Target Announced at $44 - GuruFocus